Skip to main content

Table 3 NQO1 immunohistochemical results

From: ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism

NQO1 score

nr cases

  

0 (negative)

152 (43%)

  

1 (weak)

132 (37%)

  

2 (strong)

70 (20%)

  

total

354

  
 

Grade 1

Grade 2 or 3

p-value

0 or 1

97 (35%)

179 (65%)

0.005

2

12 (18%)

56 (82%)

 
 

HER2-negative

HER2-positive

 

0 or 1

218 (82%)

48 (18%)

0.005

2

43 (66.2%)

22 (34%)

 
 

PR-negative

PR-positive

 

0 or 1

134 (49%)

137 (51%)

0.024*

2

44 (65%)

24 (35%)

 
  1. * not significant after Bonferroni correction
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us